EGFR and lung adenocarcinoma: A complete evaluation of the regulatory effects of ginsenoside Rg3 on the copy number of important EGFR exons and EGFR protein expression in lung adenocarcinoma cells from the perspectives of clinical efficacy, in vivo pharmacodynamic, and molecular biology was performed.